1-111414960-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002557.4(OVGP1):āc.1541A>Gā(p.Tyr514Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 807,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y514H) has been classified as Likely benign.
Frequency
Consequence
NM_002557.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000114 AC: 1AN: 87748Hom.: 0 Cov.: 23
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247352Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133606
GnomAD4 exome AF: 0.0000250 AC: 18AN: 719818Hom.: 0 Cov.: 0 AF XY: 0.0000337 AC XY: 12AN XY: 356304
GnomAD4 genome AF: 0.0000114 AC: 1AN: 87748Hom.: 0 Cov.: 23 AF XY: 0.0000233 AC XY: 1AN XY: 42918
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | The c.1541A>G (p.Y514C) alteration is located in exon 11 (coding exon 11) of the OVGP1 gene. This alteration results from a A to G substitution at nucleotide position 1541, causing the tyrosine (Y) at amino acid position 514 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at